Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04291885 |
| Title | Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma (I-MAT) |
| Acronym | I-MAT |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Melanoma and Skin Cancer Trials Limited |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | NZL | AUS |